Aging (Aging-US) sponsors Systems Aging Gordon Research Conference
Meeting Announcement
Aging (Aging-US) is sponsoring the Systems Aging Gordon Research Conference, “Systemic Processes, Omics Approaches and Biomarkers in Aging,” from May 29 to June 3, 2022, at the Grand Summit Hotel at Sunday River in Newry, Maine, USA.
Reporters and bloggers are invited to join top nutrition researchers and practitioners for a dynamic virtual program at NUTRITION 2022 LIVE ONLINE. The flagship meeting of the American Society for Nutrition runs June 14-16, 2022, and features research announcements, expert discussions and more.
The fourteen partners of the BiCIKL Project met in Seville (Spain) for their first physical meeting at the beginning of May, one year after the start of the project, whose mission is to catalyse a top-down culture change in the way researchers work with data about the world's biodiversity at each step of the research process. The meeting had a strong technical focus on the transition from one-sided, uni-directional linkages between biodiversity data and infrastructures to more complex bilateral and multi-directional connections across various types of FAIR and open data.
Scientists from around the world will present new findings on atoms, simple molecules, electrons and light at the 53rd Annual Meeting of the American Physical Society’s Division of Atomic, Molecular and Optical Physics (DAMOP). The meeting will be held virtually and in person at the Rosen Centre Hotel in Orlando, Florida May 30-June 3.
Press registration is open for the Ecological Society of America’s Annual Meeting, August 14-19, at the Montréal Convention Centre. Program highlights include sessions on zoonoses and the agricultural matrix, nature-based design in urban landscapes, cross-boundary fire ecology, tree species migration and more.
New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD) study were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions. The analysis found no meaningful difference in survival between patients treated with a paclitaxel drug-coated device (DCD) and those treated with a non-drug coated device (NDCD) for up to six years after the index procedure, regardless of the patient’s mortality risk and device type.
Results from early clinical evaluation of the Alleviant System to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions. This multi-center evaluation across three trial programs (ALLEVIATE-HF-1, HF-2 and HFrEF) demonstrated procedural safety and feasibility with a promising efficacy signal through six months.
A new analysis of PROGRESS-CTO (PROspective Global REgiStry for the Study of Chronic Total Occlusion Intervention; www.progresscto.org), an international multi-center registry of chronic total occlusion (CTO) percutaneous coronary intervention (PCI), was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions. The findings show an increase in the success and efficiency of CTO PCI without an increase in major adverse cardiac events (MACE).
Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin monotherapy beyond 12 months after PCI in high-risk patients during the chronic maintenance period. This study found that clopidogrel monotherapy was associated with reduced risk of net adverse clinical events (NACE; all-cause death, MI, stent thrombosis, stroke, or BARC type 2, 3, or 5 bleeding) and MACCE (death, MI, stent thrombosis, stroke), and a numerical decrease in major or clinically relevant nonmajor bleeding (BARC type 2, 3, or 5 bleeding), compared with aspirin monotherapy. The findings were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.
A study of one year outcomes in the largest cohort to date of Harmony transcatheter pulmonary valve (TPV) patients with congenital heart disease (CHD) and severe pulmonary regurgitation (PR) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions. The findings show Harmony TPV patients had favorable clinical and hemodynamic outcomes, confirming earlier results and demonstrating continued device safety and effectiveness across studies and valve types at one year.
Renowned scientists will address the latest scientific contributions in epigenetics and drug discovery for the fight against leishmaniasis and Chagas disease, two important Neglected Tropical Diseases.
Initial findings from the Distal versus Proximal Radial Artery Access for Cardiac Catheterization and Intervention (DIPRA) study were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions. The single center, randomized-controlled trial evaluated outcomes of hand function and effectiveness of conventional proximal radial artery (PRA) access compared to distal radial artery (DRA) access for cardiac catheterization.